Investment
Features
FeesSafety
Academy
More
Pluang+

Nuclear power approval could boost AI growth and reduce Bitcoin miners' sell pressure with cheaper energy.

Market News
06 Oct 2026
Crypto Briefing
View Source
Bullish
Nuclear power approval could boost AI growth and reduce Bitcoin miners' sell pressure with cheaper energy.

VanEck CEO Jan van Eck argues that approving more nuclear power plants will benefit both AI and Bitcoin mining by providing cheaper, reliable electricity. This could increase AI's value and reduce the need for Bitcoin miners to sell their holdings to cover energy costs. The U.S. is pushing to quadruple nuclear output over 25 years, with projects like the Three Mile Island reactor restart showing progress. Investors should watch nuclear approvals, restart timelines, and how Bitcoin miners adapt to AI contracts and energy costs.

VanEck's view on nuclear power and its potential impact on AI and Bitcoin comes as Pluang data shows a mixed day for cryptocurrencies. For readers following crypto markets, here is Pluang's snapshot as of Oct 07, 2026 03:33 WIB: out of 50 major cryptocurrencies, 12 rose and 37 fell. Notable movers include UNI at Rp155.141 with a 1-day change of -5.12% and a typical hold time of 65 days, BAT at Rp1.796 down 4.97% with a 93-day hold time, and COTI at Rp242 down 4.90% with a 121-day hold time.

More News

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...

Company Fundamentals
Bullish
1 hour ago
Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...

Company Fundamentals
Neutral
1 hour ago
Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...

Market News
Bullish
1 hour ago
Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...

Market News
Bearish
1 hour ago
Evercore raises Marvell's price target to $433 on strong AI and data center growth forecasts.

Evercore raises Marvell's price target to $433 on strong AI and data center growth forecasts.

Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App